Elon Musk's Partner Shivon Zilis Reveals Tesla's Plans For OpenAI Amid High-Stakes Legal Battle: Report

Shivon Zilis testified in the OpenAI-Musk trial that Musk once proposed making OpenAI a Tesla subsidiary, a plan rejected by OpenAI cofounders, and that Musk raised concerns about AI talent competition with Tesla in 2018. The article adds detail to the ongoing $134 billion lawsuit but does not indicate an immediate operational or financial impact on Tesla or OpenAI. Market relevance is mainly legal and governance-related rather than fundamental.

Analysis

The immediate market read-through is not about legal liability per se; it is about optionality compression. Every additional layer of personal conflict raises the probability that OpenAI’s strategic path becomes slower, more defensive, and more expensive to execute, which matters most to AI infrastructure names that depend on aggressive capex and model cadence. For TSLA, the incremental negative is less about direct financial exposure and more about narrative drag: Musk’s attention gets tied up in a high-friction, months-long courtroom process, which can bleed into investor confidence around product execution and governance premium.

Second-order, the testimony reinforces a broader governance discount on Musk-controlled entities. Investors may start assigning a higher probability that key strategic conversations across Tesla, xAI, and adjacent ventures are more entangled than marketed, which can widen the valuation gap versus peers with cleaner control structures. That said, the market likely already prices some version of this; the bigger risk is not the headline itself but a new evidentiary release cycle that keeps the dispute in the news through the mid-May liability phase and into any remedies stage.

The contrarian point is that this may be more noise than true economic damage for Tesla equity. If the court battle remains a reputational overhang without operational remedies, the stock can eventually refocus on delivery trends, margins, and FSD/robotics catalysts. In that sense, the setup resembles a time-decay event: near-term multiple pressure, but limited fundamental impairment unless testimony produces concrete evidence of misappropriation, anticompetitive conduct, or formal injunction risk.

For OpenAI-adjacent competitors, the real beneficiary is not necessarily a named public company but the cluster of enterprise AI vendors and infrastructure suppliers that can exploit any slowdown in OpenAI’s decision-making. A prolonged dispute gives Microsoft, Anthropic, Google, and model-agnostic infrastructure stacks a window to win workloads from customers seeking procurement certainty. The longer the case stretches, the more it benefits buyers of diversified AI exposure versus single-vendor narratives.

Key Decisions for Investors

• Short TSLA tactically into the next 2-6 weeks if legal headlines remain active; use a defined-risk put spread rather than outright short stock, targeting modest downside from governance overhang with limited premium at risk.
• Pair trade: long MSFT / short TSLA over 1-3 months. Thesis: MSFT has cleaner AI monetization optionality and less key-man/legal distraction, while TSLA absorbs headline risk and potential multiple compression.
• If you want convexity on the dispute dragging into mid-May, buy TSLA May or June downside puts on strength. Best entry is after any relief rally tied to non-legal news, with the idea that legal overhang reasserts itself as new testimony hits.
• Avoid chasing OpenAI-linked enthusiasm in single-name AI winners until trial risk clears; prefer diversified AI infrastructure exposure over pure model-story bets for the next 1-2 quarters.
• Contrarian long: if TSLA sells off sharply on another courtroom headline, consider fading the move with a small size call spread against a multi-month horizon, since the damage appears more narrative than balance-sheet unless new facts materially worsen the case.